4//SEC Filing
Rojkjaer Lisa 4
Accession 0001209191-22-020078
CIK 0001061027other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:34 PM ET
Size
8.0 KB
Accession
0001209191-22-020078
Insider Transaction Report
Form 4
Rojkjaer Lisa
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-17+150,000→ 150,000 totalExercise: $3.04Exp: 2032-03-17→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares subject to the option shall vest on the date one month following February 23, 2022 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001846460
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:34 PM ET
- Size
- 8.0 KB